Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China
在美国和中国,对既往接受过治疗的晚期透明细胞肾细胞癌患者,使用贝祖替凡与依维莫司的成本效益进行分析
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251379708
Ding, Baolong; Yao, Hongting; Tao, Tiantian; Sun, Yuyang; Zhu, Yulu; Zhu, Haomin; Wang, Jia; Jing, Zhuying; Gao, Lihong; Lin, Yingtao; Li, Xin